Fate Therapeutics (FATE) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.07 +0.01 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.06 | 52 Week High | $4.76 | |||
| Open | $2.05 | 52 Week Low | $1.46 | |||
| Day High | $2.09 | P/E | N/A | |||
| Day Low | $2.03 | EPS | $-1.91 | |||
| Volume | 923,557 | |||||
